Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Pullen

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Kidney International|February 6, 2018
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests developmentNatalia Nowak, Jan Skupien, Adam M Smiles, et al.
Biochemistry|February 25, 2015
Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-βJun Kuai, Lidia Mosyak, Jon Brooks, et al.
Diabetes|July 10, 2013
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet functionS Armando Villalta, Jiena Lang, Samantha Kubeck, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2015
Bridging Translation by Improving Preclinical Study Design in AKIMark de Caestecker, Ben D Humphreys, Kathleen D Liu, et al.
SSM - Population Health|August 10, 2023
Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic: An intersectional analysisElsa Lorthe, Viviane Richard, Roxane Dumont, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2011
The translational efficacy of a nonsteroidal progesterone receptor antagonist, 4-[3-cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on endometrial growth in macaque and humanDavid C Howe, Natalie M Mount, Kirsty Bess, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Sulfonamides as selective oestrogen receptor β agonistsLee R Roberts, Duncan Armor, Carolyn Barker, et al.
Kidney International|April 12, 2017
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal diseaseMasayuki Yamanouchi, Jan Skupien, Monika A Niewczas, et al.
BMJ Open|February 2, 2022
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, SwitzerlandHelene Baysson, Francesco Pennachio, Ania Wisniak, et al.
BMJ Open|November 21, 2022
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological studyRoxane Dumont, Mayssam Nehme, Elsa Lorthe, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Kidney International|February 6, 2018
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests developmentNatalia Nowak, Jan Skupien, Adam M Smiles, et al.
Biochemistry|February 25, 2015
Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-βJun Kuai, Lidia Mosyak, Jon Brooks, et al.
Diabetes|July 10, 2013
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet functionS Armando Villalta, Jiena Lang, Samantha Kubeck, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2015
Bridging Translation by Improving Preclinical Study Design in AKIMark de Caestecker, Ben D Humphreys, Kathleen D Liu, et al.
SSM - Population Health|August 10, 2023
Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic: An intersectional analysisElsa Lorthe, Viviane Richard, Roxane Dumont, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2011
The translational efficacy of a nonsteroidal progesterone receptor antagonist, 4-[3-cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on endometrial growth in macaque and humanDavid C Howe, Natalie M Mount, Kirsty Bess, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Sulfonamides as selective oestrogen receptor β agonistsLee R Roberts, Duncan Armor, Carolyn Barker, et al.
Kidney International|April 12, 2017
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal diseaseMasayuki Yamanouchi, Jan Skupien, Monika A Niewczas, et al.
BMJ Open|February 2, 2022
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, SwitzerlandHelene Baysson, Francesco Pennachio, Ania Wisniak, et al.
BMJ Open|November 21, 2022
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological studyRoxane Dumont, Mayssam Nehme, Elsa Lorthe, et al.
Pageof 6